Aster DM Health News

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 16th Annual General Meeting (AGM) of the Company was held on Thursday, August 29, 2024 at 11.30 AM (IST) through Video Conferencing or other Audio - Visual Means and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the proceedings of the AGM in compliance with the provisions of aforesaid regulations.

This is further to our earlier letter dated August 01, 2024, regarding video/ audio recordings of earning call of the Company for the quarter ended June 30, 2024 held on August 01, 2024. please find enclosed the transcript of the said earnings call

Pursuant to Regulation 30 and 47 of SEBI Regulations, please find enclosed the copies of the newspaper advertisement published on August 07, 2024 in financial express (English Language) and Vijayavani (Kannada Language), for giving information pertaining to 16th Annual General Meeting of the Company to be held on Thursday, August 29, 2024 at 11.30 AM (IST) through video conferencing/ other audio visual means. We request you to kindly take the above said information on record.

Please find enclosed the general communication sent to shareholders w.r.t deduction of tax at source on declaration of dividend by the Company. Request you to kindly take the same on record.

Pursuant to regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the business responsibility and sustainability report for the financial year 2023-24, which forms part of the integrated annual report of the Company. We request you to kindly take the above said information on record.

With reference to captioned subject, we wish to inform you that the 16th Annual General Meeting ('AGM') of Aster DM Healthcare Limited ("the Company") is scheduled to be held on Thursday, August 29, 2024 at 11:30 A.M (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'), in compliance with applicable circulars issued by the Ministry of Corporate Affairs ('MCA circulars'), the Securities and Exchange Board of India ('SEBI circulars') and other applicable provisions of the Companies Act, 2013, to transact the businesses as set forth in the Notice of AGM. Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the Notice of the Annual General Meeting and Integrated Annual Report for the financial year 2023-24. We request you to kindly take the above said information on record.

With reference to the captioned subject , please be informed that the 16th Annual General Meeting (AGM) of Aster DM Healthcare Limited is scheduled to be held on thursday, August 29, 2024 at 11.30 AM (IST) through video conferencing or other audio visual means (OAVM), in compliance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India and other applicable provisions of the Companies Act, 2013 to transact the businesses as set forth in the notice of the AGM. We request you to kindly take the same on record.

Pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015, We would like to inform that Dr. Nitish Shetty, Chief Executive Officer, a Senior Management Personnel of the Company, vide his letter dated 05th August 2024, tendered his resignation for pursuing an entrepreneurial opportunity and has informed that there are no other reasons for his resignation except the reason mentioned in the resignation letter.We request you to kindly take the above information on record.

Pursuant to Regulation 30 and 47 of SEBI Regulations, please find enclosed the copies of newspaper advertisement published on August 03, 2024, in Financial Express (English Language) and Vijayavani (Kannada Language), in compliance with the Ministry of Corporate Affairs circulars intimating that the 16th Annual General Meeting of the Company will be held on Thursday, August 29, 2024 at 11.30 AM (IST) through Video Conferencing/ Other Audio Visual Means. We request you to kindly take the same on record.

With reference to the captioned subject, please be informed that the Earnings Call of the Company for the quarter ended June 30, 2024, was held today August 01, 2024, and the Video/Audio Recording with respect to Earnings Call is available on the website of the Company at https://www.asterdmhealthcare.in/investors/financial-information/audio-video-recordings-earnings-quarterly-calls Kindly take the above said information on record as per the requirement of SEBI Listing Regulations.

With reference to the above captioned subject, please find enclosed the Investor Presentation on the Company''s Performance for the quarter ended June 30, 2024. Kindly take the above said information on record.

With reference to the above captioned subject, please find enclosed press release in relation to the unaudited financial results of the Company for the quarter ended June 30, 2024. Kindly take the above said information on record as per the requirement of SEBI (LODR) Regulations, 2015.

With reference to the above captioned subject, please be informed that the Board of Directors of the Company at their meeting held on July 31, 2024 have approved the appointment of Directors of the Company with effect from July 31, 2024. We request you to kindly take the above said information on record.

The Board of Directors at their meeting held on July 31, 2024 have, inter alia, approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2024. Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board of Directors at their meeting held on July 31, 2024 have inter alia approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2024. Kindly take the above said information on record as per the requirement of SEBI (LODR) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Earnings Conference Call with analysts/ Investors is scheduled on Thursday, August 01, 2024 at 11:00 AM (IST) in relation to the Unaudited Financial Results for the quarter ended June 30, 2024. We request you to kindly take the above information on record.

Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 ,inter alia, to consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the quarter ended June 30, 2024. We request you to kindly take the same on record.

With reference to the above captioned subject, we would like to inform you that Malabar Institute of Medical Sciences Limited ("MIMS"), a material subsidiary of Aster DM Healthcare Limited ("Company"), has entered into definitive agreements on 19th July, 2024 to acquire additional 25% stake in Usolar Assetco Two Private Limited from U- solar Clean Energy Solutions Private Limited on 19th July, 2024. We request you to kindly take the above information on record.

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed confirmation certificate for the quarter ended June 30, 2024.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG

Please be informed that in compliance with SEBI (PIT) Regulations, 2015 and the Code for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in securities of the Company shall be closed for the Designated Persons from July 01, 2024 and would be re-opened after 48 hours from the date of announcement / declaration of un-audited financial results (standalone and consolidated) of the Company for the quarter and three months ended June 30, 2024. We request you to kindly take the same on record.

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 , please be informed that Mr. Farhan Yasin, Vice President - Kerala, Tamil Nadu & Retail Cluster, a Senior Management Personnel of the Company, vide his letter dated 24th June, 2024 tendered his resignation for personal reasons and has also informed that there are no other reasons for his resignation except the reason mentioned in his resignation letter. We request you to kindly take the above said information on record.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Olympus Capital Asia Investments Ltd

According to bulk deal data from BSE, Olympus Capital Asia Investments sold 4.50 crore shares, equivalent to a 9% stake in Aster DM Healthcare, in two tranches. The shares were sold within the price range of Rs 340 to Rs 340.13 each, totalling Rs 1,530.08 crore.

Equity indices soar with YES Bank's fundraising. IndiGo partners with Garuda for pilot training. Olympus Capital Asia to sell 5% of Aster DM Healthcare. ONGC appoints Devendra Kumar as CFO. Bank of Baroda appoints Chayani Manoj sundar as CFO.

Olympus Capital Asia Investments is set to trim its stake in Aster DM, with a base offering of 2.5 crore shares, representing 5% of the company. Olympus currently holds a 10.1% stake in Aster DM.

With reference to the captioned subject, please find enclosed presentation to be made to Investors in the upcoming investor meetings and investor conference. Request you to kindly take the above said information on record.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Investec Investor conference' and shall be meeting various investors at Singapore on 19th June, 2024 and at Hong Kong on 20th June, 2024. We request you to kindly take the above information on record.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Nuvama Investor conference' and shall be meeting various investors on June 18, 2024 at Mumbai. We request you to kindly take the above information on record.

This is further to our earlier letter dated May 29, 2024, regarding video/audio recordings of earning call of the Company for the quarter and year ended March 31, 2024, please find enclosed herewith the transcript of the said earnings call.

Leading hospital chains in India have reported improved average revenue per operating bed (ARPOB) and profitability in the latest quarter, driven by better payer mix and cost control measures. Expansion plans are underway, with a focus on markets like Bengaluru and Mumbai, through asset-light models. Adjacent businesses such as diagnostics, virtual care, and digital healthcare platforms are also seeing growth. However, regulatory proposals to rationalize rates may pose risks to sector valuations.

Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services and Consultancy Income for the year ending 31-Mar-2023.

With reference to the captioned subject please be informed that the Earnings Call of the Company for the quarter and year ended March 31, 2024, was held today, May 29, 2024 and the Video/Audio Recording with respect to Earnings Call is available on the website of the Company at https://www.asterdmhealthcare.com/investors/financial-information/audio-video-recordings-earnings-quarterly-calls . Kindly take the above said information on record as per the requirement of SEBI Listing Regulations.

Pursuant to Regulation 24A of SEBI (Listing Obligation and Disclosure Requirements) (Amendment) Regulations, 2018 read with SEBI circular no: CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2024. We request you to kindly take this on record.

With reference to the above captioned subject, Please find enclosed the Investor Presentation on the Company''s performance for the quarter and year 31st March, 2024. Kindly take the above said information on record.

With reference to the above captioned subject, Please be informed that the Company wishes to update that following the receipt of an anonymous complaint pertaining to certain employees of the Company and its subsidiaries, the Company undertook a review with the assistance of a third party and identified certain instances requiring disclosure under the SEBI (LODR) Regulations. Kindly take the above said information on record.

With reference to the above captioned subject, please find enclosed press release in relation to the audited financial results of the Company for the quarter and year ended 31st March, 2024. We request you to kindly take the above said information on record.

Please be informed that the Record date for determining the eligibility of shareholders to vote on the resolutions proposed at the 16th Annual General Meeting of the Company and for the payment of the Final Dividend has been fixed as August 22, 2024. We request you to kindly take the above said information on record.